KAINOS Laboratories,Inc. (4556.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

May 14May 19May 22May 27Jun 1Jun 4Jun 9Jun 12

ValuationView details →

P/E (Fwd)

16.0x

EV/EBITDA

7.0x

Market Cap

JPY 9.56B

MomentumView details →

1D Return

+0.00%

YTD Return

+78.44%

RSI (14)

52.0

ValuationView details →

P/E (Fwd)

16.0x

EV/EBITDA

7.0x

Market Cap

JPY 9.56B

RSI (14)

52.0

MomentumView details →

1D Return

+0.00%

YTD Return

+78.44%

ProfitabilityView details →

Gross Margin

49.03%

Net Margin

10.94%

EBITDA Margin

16.98%

ROE (TTM)

8.39%

ROA (TTM)

6.65%

Asset Turnover

0.61x

GrowthView details →

Revenue YoY

+2.58%

EPS YoY

+8.47%

FCF YoY

—

Revenue CAGR 3Y

+4.76%

EPS CAGR 3Y

+6.36%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.08x

Current Ratio

4.11x

Quick Ratio

3.86x

Div Yield

1.41%

Div Rate

—

Div Growth 1Y

+9.38%

Financials snapshotView financials →

Revenue (TTM)

5.46B

Net Income (TTM)

597.00M

Op. CF (TTM)

—

Latest newsMore news →

No recent news for 4556.T.

Similar companies

Immuno-Biological Laboratories Co.,Ltd.4570.T K Pharma,Inc.4896.T MORISHITA JINTAN CO.,LTD.4524.T WAKAMOTO PHARMACEUTICAL CO.,LTD.4512.T Kidswell Bio Corporation4584.T OncoTherapy Science,Inc.4564.T Find similar companies →

Latest newsMore news →

No recent news for 4556.T.